Florida Statutes 456.62 – Communication of COVID-19 treatment alternatives
Current as of: 2024 | Check for updates
|
Other versions
Terms Used In Florida Statutes 456.62
- Health care practitioner: means any person licensed under chapter 457; chapter 458; chapter 459; chapter 460; chapter 461; chapter 462; chapter 463; chapter 464; chapter 465; chapter 466; chapter 467; part I, part II, part III, part V, part X, part XIII, or part XIV of chapter 468; chapter 478; chapter 480; part I, part II, or part III of chapter 483; chapter 484; chapter 486; chapter 490; or chapter 491. See Florida Statutes 456.001
(1) A health care practitioner treating a patient diagnosed with COVID-19 shall obtain the informed consent of the patient or the patient’s legal representative before prescribing any medication for the treatment of COVID-19.
(2) To obtain informed consent, the health care practitioner must provide an explanation of alternative medications for the treatment of COVID-19 and the relative advantages, disadvantages, and risks associated with such alternative medications to the extent necessary to allow the patient or the patient’s legal representative to make a prudent decision regarding treatment.
(3) In determining which alternative medications to present to a patient for purposes of obtaining informed consent, the health care practitioner must include any medications currently authorized or approved by the United States Food and Drug Administration for the treatment of COVID-19 and use his or her best clinical judgment to identify any alternative medications that could reasonably be expected to benefit the patient.
(4) In providing such information regarding alternative medications, the health care practitioner shall take into consideration the physical state of the patient and the patient’s ability to understand the information.
(5) A health care practitioner treating a patient diagnosed with COVID-19 shall indicate on such patient’s medical record the health care practitioner’s compliance or noncompliance with this section.
(6) This section does not supersede any other provision of law regarding informed consent.